CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $32,997,000 | +33.0% | 306,890 | +53.9% | 0.01% | +25.0% |
| Q3 2016 | $24,819,000 | +133.9% | 199,382 | +99.8% | 0.00% | +100.0% |
| Q2 2016 | $10,609,000 | +354.0% | 99,786 | +508.3% | 0.00% | – |
| Q4 2015 | $2,337,000 | +1.6% | 16,405 | -36.0% | 0.00% | – |
| Q3 2015 | $2,301,000 | -90.4% | 25,623 | -87.7% | 0.00% | -100.0% |
| Q2 2015 | $23,944,000 | +235.0% | 207,916 | +177.8% | 0.00% | +300.0% |
| Q1 2015 | $7,148,000 | +116.7% | 74,842 | +52.5% | 0.00% | 0.0% |
| Q4 2014 | $3,299,000 | +6.7% | 49,077 | -14.3% | 0.00% | 0.0% |
| Q3 2014 | $3,091,000 | +17.3% | 57,283 | -3.4% | 0.00% | – |
| Q2 2014 | $2,636,000 | +31.3% | 59,287 | +2.6% | 0.00% | – |
| Q1 2014 | $2,008,000 | -19.9% | 57,794 | -33.5% | 0.00% | – |
| Q4 2013 | $2,506,000 | -6.2% | 86,875 | -5.1% | 0.00% | -100.0% |
| Q3 2013 | $2,673,000 | +4.4% | 91,511 | -17.1% | 0.00% | 0.0% |
| Q2 2013 | $2,560,000 | – | 110,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |